English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 24, 2024

American Lung Association Report: Idaho Struggles with Short-Term Particle Pollution in “State of the Air” Report Findings
+ Pharmaceuticals
Patient Daily | Apr 24, 2024

American Lung Association Report: Alaska Receives Mixed Marks for Short-Term Particle Pollution
+ Pharmaceuticals
Patient Daily | Apr 24, 2024

Scientists Unveil Genetics Behind Development of Gliding
+ Pharmaceuticals
Patient Daily | Apr 24, 2024

Bangor, ME Metro Area Ranked One of Cleanest Cities in the U.S., According to the 25th Annual ‘State of the Air’ Report
+ Pharmaceuticals
Patient Daily | Apr 24, 2024

Washington struggles with particle pollution: American Lung Association Report
+ Pharmaceuticals
Patient Daily | Apr 24, 2024

American Lung Association Report: Utah Receives Poor Grades for Ozone and Particle Pollution
+ Pharmaceuticals
Patient Daily | Apr 24, 2024

American Lung Association Report: Montana Struggles With Air Quality Following Wildfires and Lands on Most Polluted List
+ Pharmaceuticals
Patient Daily | Apr 24, 2024

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation